2918.99.20 | 15 | 2-Methyl-4-chlorophenoxyacetic acid | kg | | | |
2921.22.10 | 00 | Derived in whole or in part from adipic acid | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,MA,MX,P) 3.4% (SG) | 15.4¢/kg + 66.5% |
2921.42.21 | 00 | Metanilic acid | kg | 6.5% | Free (A,AU,BH,CA, CL,E,IL,J,JO, L,MA,MX,P) 0.1¢/kg + 3.3% (SG) | 15.4¢/kg + 60% |
2921.42.22 | 00 | Sulfanilic acid | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,MA,MX,P) 0.1¢/kg + 3.3% (SG) | 15.4¢/kg + 60% |
2921.59.20 | 00 | 4,4'-Diamino-2,2'-stilbenedisulfonic acid | kg | 6.5% | Free (A,AU,BH,CA, CL,E,IL,J,JO, MA,MX, P,SG) | 15.4¢/kg + 80% |
2922.41.00 | 10 | Meeting requirements of Food Chemical Codex, Codex Alimentarius or United States Pharmacopeia | kg | | | |
2922.49.40 | 15 | l-Aspartic acid | kg | | | |
2922.49.60 | 00 | 3-Aminocrotonic acid, methyl ester; and ¢/- α-Amino-1,4-cyclohexadiene-1- acetic acid | kg | Free | | 25% |
2924.21.12 | 00 | 1-(2-Methylcyclohexyl)-3-phenylurea | kg | Free | | 15.4¢/kg + 48.5% |
2924.21.18 | 00 | sym-Diethyldiphenylurea | kg | 6.5% | Free (A,AU,BH,CA, CL,E,IL,J,JO, MA,MX,P) 0.2¢/kg + 3.3% (SG) | 15.4¢/kg + 58% |
2924.23.10 | 00 | 2-Acetamidobenzoic acid | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,MA,MX,P) 0.2¢/kg + 3.3% (SG) | 15.4¢/kg + 58% |
2924.29.05 | 00 | Biligrafin acid; 3,5-Diacetamido-2,4,6-triiodobenzoic acid; and Metrizoic acid | kg | 5.3% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,MA,MX, P,SG) | 15.4¢/kg + 34% |
2930.90.49 | 10 | Thioglycolic acid | kg | | | |
2932.99.35 | 00 | 2-Hydroxy-3-dibenzofurancarboxylic acid | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,MA,MX, P,SG) | 15.4¢/kg + 66.5% |
2933.29.05 | 00 | 1-[1-((4-Chloro-2-(trifluoromethyl)phenyl)- imino)-2-propoxyethyl]-1H-imidazole (Triflumizole); and Ethylene thiourea | kg | Free | | 15.4¢/kg + 52% |
2933.39.20 | 00 | p-Chloro-2-benzylpyridine; 4-Chloro-1-methylpiperidine hydrochloride; 1,4-Dimethyl-6-hydroxy-3-cyanopyrid-2-one; Di-(2,2,6,6-tetramethyl-4-hydroxy- piperidine)sebacate; 2-Methyl-5-ethylpyridine; 4-Phenylpropylpyridine; α-Phenylpyridylacetic acid, methyl ester; Picolinic acid; 2-Pyridinecarboxaldehyde; and 2,5-Pyridinedicarboxylic acid | kg | 5.8% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,MA,MX, P,SG) | 15.4¢/kg + 39.5% |
2933.69.60 | 15 | Sodium dichloroisocyanurate and trichloroisocyanuric acid | kg | | | |
2934.99.70 | 00 | Morpholinoethyl chloride hydrochloride; 2-Methyl-2,5-dioxo-1-oxa-2-phospholan; and (6R-trans)-7-Amino-3-methyl-8-oxo-5- thia-1-azabicyclo[4.2.0]-oct-2-ene-2- carboxylic acid | kg | Free | | 30.5% |
2936.29.10 | 00 | Folic acid | kg | Free | | 15.4¢/kg + 49% |
3002.10.01 | 10 | Human blood plasma | kg | | | |
3002.10.01 | 20 | Normal human blood sera, whether or not freeze-dried | kg | | | |
3002.10.01 | 30 | Human immune blood sera | kg | | | |
3002.90.51 | 10 | Whole human blood | kg | | | |
3006.30.10 | 00 | Containing antigens or antisera | kg | Free | | Free |
3201.90.10 | 00 | Tannic acid, containing by weight 50 percent or more of tannic acid | kg | 1.5% | Free (A,AU,BH, CA,CL,E,IL,J,JO, MA,MX, P,SG) | 8% |